EXAS - Exact Sciences Corporation

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue99,37639,4371,798
Cost of Revenue45,19524,5014,325
Gross Profit54,18114,936-2,527
Operating Expenses
Research Development33,47333,91428,669
Selling General and Administrative189,724140,09069,343
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-169,016-159,068-100,539
Income from Continuing Operations
Total Other Income/Expenses Net2,0181,271542
Earnings Before Interest and Taxes-166,998-157,797-99,997
Interest Expense213651
Income Before Tax-167,211-157,803-100,048
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-167,211-157,803-100,048
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-167,211-157,803-100,048
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-167,211-157,803-100,048